Contrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy()

od Corcioni, B., Santilli, L., Quercia, S., Zamagni, C., Santini, D., Taffurelli, M., Mignani, S.
Wydane 2008

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

od Bengala, C, Zamagni, C, Pedrazzoli, P, Matteucci, P, Ballestrero, A, Da Prada, G, Martino, M, Rosti, G, Danova, M, Bregni, M, Jovic, G, Guarneri, V, Maur, M, Conte, P F
Wydane 2006

Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

od Cazzaniga ME, Biganzoli L, Cortesi L, De Placido S, Donadio M, Fabi A, Ferro A, Generali D, Lorusso V, Milani A, Montagna E, Munzone E, Orlando L, Pizzuti L, Simoncini E, Zamagni C, Pappagallo GL
Wydane 2019-04-01

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical a...

od Pellegrino, B., Cavanna, L., Boggiani, D., Zamagni, C., Frassoldati, A., Schirone, A., Caldara, A., Rocca, A., Gori, S., Piacentini, F., Berardi, R., Brandes, A.A., Foglietta, J., Villa, F., Todeschini, R., Tognetto, M., Naldi, N., Bortesi, B., Montemurro, F., Ardizzoni, A., Boni, L., Musolino, A.
Wydane w ESMO Open (2020)